Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "2023"

1144 News Found

Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr
News | January 28, 2025

Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr

The 33% year-over-year revenue growth and a remarkable 45% surge in gross profit reflect our strong market presence and efficient execution across therapeutic segments


Torrent Pharmaceuticals posts Q3 FY25 consolidated PAT at Rs. 503 Cr
News | January 28, 2025

Torrent Pharmaceuticals posts Q3 FY25 consolidated PAT at Rs. 503 Cr

Torrent Pharmaceuticals has reported total income of Rs. 2,842 crores during the period ended December 31, 2024


RPG Life Sciences posts Q3 FY25 PAT higher at Rs. 34.93 Cr
News | January 28, 2025

RPG Life Sciences posts Q3 FY25 PAT higher at Rs. 34.93 Cr

RPG Life Sciences has reported total income of Rs. 176.02 crore during the period ended December 31, 2024


Laurus Labs posts Q3 FY25 consolidated PAT higher at Rs. 92.30 Cr
News | January 28, 2025

Laurus Labs posts Q3 FY25 consolidated PAT higher at Rs. 92.30 Cr

Laurus Labs has reported total income of Rs. 1,424.47 crores during the period ended December 31, 2024


AstraZeneca plans US$ 570 million investment in Canada
News | January 27, 2025

AstraZeneca plans US$ 570 million investment in Canada

700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies


Piramal Critical Care announces US launch of Chlorpromazine Hydrochloride for Injection
News | January 23, 2025

Piramal Critical Care announces US launch of Chlorpromazine Hydrochloride for Injection

The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care


Dr Reddy’s Labs Q3 FY25 profit up 2% YoY at Rs. 1,413 Cr
News | January 23, 2025

Dr Reddy’s Labs Q3 FY25 profit up 2% YoY at Rs. 1,413 Cr

The revenue from operations in Q3 FY25 is Rs. 8,358.6 crore, up 16% YoY


Moderna announces updates on pandemic influenza program
News | January 21, 2025

Moderna announces updates on pandemic influenza program

The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines


Alleima completes the acquisition of medical components firm Endox
Medical Device | January 16, 2025

Alleima completes the acquisition of medical components firm Endox

In 2023, Endox had revenues of approximately SEK 65 million


ZIM Laboratories and Neuraxpharm granted marketing authorization for Buprenorphine Sublingual Film in Europe
News | January 10, 2025

ZIM Laboratories and Neuraxpharm granted marketing authorization for Buprenorphine Sublingual Film in Europe

According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually